sible effect of maternal immunity in piglets on test performance.
Acknowledgements. We thank Evelyn Townsend for technical assistance and Dr. John Deen for critical review of the manuscript. R. M. C. Guedes was supported by the Brazilian government sponsoring agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Universidade Federal de Minas Gerais. beef industries continues to improve, Johne's disease is becoming of increasing concern to veterinarians and producers. This disease has a slow insidious onset, which may result in significant production losses before the infected animal has overt clinical signs. 1, 2, 6, 10 In addition, animals can often shed the causal organism, Mycobacterium avium subspecies paratuberculosis (MAP), in their feces before showing clinical signs, resulting in contamination of the production environment and increased likelihood for the infection of other animals in the herd. 8, 9 As a result of these factors, and the progressively greater awareness of the disease by producers, submissions to diagnostic laboratories of both serum and fecal samples for Johne's disease testing have increased steadily. Fecal culture for MAP is considered to have 100% specificity, and variable sensitivity often reported to be around 50%. 3 The serum-based tests currently available use enzymelinked immunosorbent assay (ELISA) technology to identify antibodies to the causal organism. The ELISAs have a variety of sensitivity and specificity values reported in the literature, with most publications reporting approximately 95% specificity and 50% sensitivity. 3, 4, 7 The reported sensitivity and specificity values are based on a single recommended cutoff point that is used to differentiate a negative from a positive result. Variation in test results due to inherent test variability and laboratory-specific factors were evaluated with a panel of samples encompassing the spectrum of results expected from a commercially available ELISA. a In an effort to improve the diagnostic interpretation of Johne's disease ELISA results, positive, negative, and suspect ranges for the numerical reporting of ELISA results also were established, rather than dichotomizing the data into only negative or positive classifications as recommended by the manufacturer.
Sources and manufacturers
With the commercial kit evaluated in this study, the test results are reported as a sample to positive (S/P) ratio reflecting the following equation, where OD is optical density:
S/P ratio sample OD Ϫ negative control OD ϭ . positive control OD Ϫ negative control OD Serum samples with S/P ratios less than 0.25 are classified as negative for MAP antibodies and values greater than or equal to 0.25 are classified as positive for MAP antibodies. The manufacturer's protocol recommends that individual samples be tested in duplicate (2 wells in a single plate) with the calculated mean OD value used to determine the S/P ratio, but also notes that a single-well test is acceptable. In the current evaluation, 201 samples were tested in single wells to mimic the practice most commonly used in diagnostic laboratories. The serum samples were from adult cattle from 52 different dairies in California and were selected from a bank of bovine serum samples that previously had been tested for Johne's disease antibody with the same manufacturer's ELISA kit. The spectrum of original S/P values for the samples is given in Table 1 . Each sample was tested on 5 separate dates in each of 2 different laboratories for a total of 10 replicates for each sample. Within a given laboratory, each of the 5 replicate tests was performed a minimum of 1 week apart with the 2 laboratories performing the tests on approximately the same dates. In laboratory A, 2 technicians performed the majority of the testing, with each performing the testing 2 or 3 times. In 1 of the replicates performed in laboratory A, 4 of the samples were tested by 1 technician and the other 197 samples were tested by a second technician. In laboratory B, 2 technicians performed the testing 1 or 4 time(s) each. Each of the technicians involved had passed a national proficiency test for the ELISA method of detecting antibodies to MAP in bovine serum.
The technical staff was blinded to the study and the test samples were included in the laboratory's routine sample flow. Five lot numbers of the ELISA kit were used to perform the testing. Each individual lot of the kit was used for 1, 1, 2, 2, or 4 of the testing replicates. For all the test runs combined, average OD and standard deviation of the OD were 0.079 Ϯ 0.014 for the negative control sera included with the kit and 0.592 Ϯ 0.055 for the positive control sera. The negative and positive control sera performed according to the manufacturers' specifications on each individual test run. Six samples and associated data were removed from the analysis, including samples where technicians expressed concern about sample identification in 1 or more of the replicates. Samples with an overall mean S/P ratio of greater than 0.7 are not included in graphic results shown but were included in statistical analysis.
The coefficient of variation (CV) of results is a measure of test precision and reflects the expected performance of a test. The CV is calculated as the ratio of the standard deviation to the mean for a set of results and can be used to quantify the repeatability of results for a given sample. A 10% CV has been recommended for ELISA-based technology; 5 however, experience indicates that the CV for commercial kits is more typically between 10 and 20%. The CV for the S/P ratio for the combined test results from both of the laboratories was greater than 20% in 87% of the samples and, as expected, the CV was highest in the samples with lower mean S/P ratios. The mean CVs were 0.4102 and 0.3140 for laboratory A and B, respectively. The mean S/P ratios of the results for each of the 201 samples provided by the 2 laboratories were statistically different (P ϭ 0.004; Fig.  1 ) but the mean OD was not different (P ϭ 0.876) when analyzed with a t-test and normalizing the data by rank-order transformation. Analysis of the differences in S/P ratio and in CV between the 2 laboratories ignores any differences that might be due to unequal distribution of kit lots or technicians between the laboratories.
Although the project was originally designed to estimate the overall variability in results for serum samples submitted to 2 independent laboratories, additional information was collected that allowed for a rough assessment of possible sources of variation in OD values and S/P ratios. Factors tested to assess their effect on the S/P ratio and on the OD were kit lot designation, laboratory performing the test, technician performing the test, and laboratory case number. To effectively blind the technicians performing the testing, samples were submitted as routine diagnostic cases, with the laboratory case numbers assigned to the samples before testing. In addition, the 201 samples were in a different random order on each of the cases. Case number was included as a random variable and was an inverse proxy for sample storage time, where a higher case number represented a longer storage time. Differences in mean rank-order-transformed S/ P ratios and OD values due to these factors were assessed by a mixed-model analysis of variance with commercial statistical software. b The S/P ratio and OD were significantly associated with case number (P Ͻ 0.001 for both) and kit lot number (P ϭ 0.041 and P ϭ 0.092, respectively). When case number was removed from analysis, kit lot number, laboratory, and technician performing the testing all become significant for both S/P ratio and OD (P Ͻ 0.001 for all). Upon examination of the mean OD and S/P ratios provided by the different lot numbers of the kit, it was noted that 2 of the lots provided extreme values. One had the highest mean values and the second had the lowest mean values. Both of these lot numbers of the kit were used by the same technician in laboratory A but not by any other technician. No significant effect of kit lot number on OD or S/P ratios was obtained when results provided by these 2 lot numbers of the kit were removed from the analyses. The significant relationship of kit lot number with the OD and S/P ratios for the samples indicates that individual lots of the test kit can provide different test results, thus negatively influencing the reproducibility and precision of the test. As mentioned previously, case number was found to be significantly related to both OD and S/P values for the individual samples. When the results of the different case numbers were studied, no credible explanation for this relationship could be made. The hypothesis that differences in serum storage time might cause differing results was not found because the test replicates with the highest and lowest mean result values for the 2 laboratories did not correspond with higher or lower case numbers (data not shown).
A random-effects model that considered the variability of the S/P ratio among samples and the variability of the S/P ratio among replicates of each sample was used to evaluate the interassay variability in ELISA S/P values. A parametric bootstrap method with 5,000 iterations was used to obtain 85, 90, and 95% prediction intervals of the S/P ratio and, subsequently, to obtain reproducibility limits around the manufacturer's recommended ELISA cutoff value of 0.25, between which results would be interpreted as suspicious. The model, when using the data obtained from the repeat testing of the 201 samples, identified suspicious ranges around the 0.25 cutoff of 0.2-0.35 (85% prediction interval), 0.11-0.41 (90% prediction interval), and 0.10-0.43 (95% prediction interval). The prediction intervals reported here indicate the level of confidence that a sample classified as negative or positive would repeatedly test below 0.25 or above 0.25 on different kits or different test runs. As an example, for the 85% prediction interval, only those samples testing Ͻ0.2 can be expected to repeatedly have results be-low the manufacturer's designated 0.25 interpretation point, and only those samples testing Ͼ0.35 can be expected to repeatedly have results above the designated 0.25 interpretation cutoff.
The results of this study show that the variability in the test results provided by repeat testing of the same serum sample with a commercial Johne's disease ELISA kit can result in discordant interpretation of those results when using a single cutoff point for dichotomous classification of results as either positive or negative, as is the typical practice in diagnostic testing. To utilize the maximum amount of information from the test, and incorporate expected variation into the interpretation, the suggestion is made that test results include the S/P ratios and a classification scheme for characterizing the results as negative, suspect, or positive. When using the data generated in this study and incorporating assay and laboratory variability, S/P ratios between 0.2 and 0.35, for example, incorporate the values where misclassification would occur at the 85% prediction interval, and results in this range are more appropriately classified as suspicious. This study does not attempt to validate the sensitivity and specificity of the test but rather is aimed at defining a way to more reliably and appropriately interpret the results of the commercial Johne's disease ELISA test kit evaluated. If the true infection status of individual animals is accurately indicated by the manufacturer's suggested cutoff point of 0.25, the proposed classification scheme, with results between 0.2 and 0.35 being classified as suspect, minimizes the probability of incorrectly classifying an animal as positive or negative for antibodies to MAP.
In conclusion, this study documents the level of variability in results from a representative ELISA test for Johne's disease and indicates that this variability has a significant negative influence on the confidence in the result interpretation based on a single test, particularly for those results near the manufacturers suggested cutoff point. Possible sources of variability, some of which were crudely examined in this study, include the kit lot number, temperature of reagents at the time of the assay, ELISA plate readers, technicians, pipette calibrations, sample quality, immune status of the individual animal, and a variety of other factors that warrant further investigation. This variability, innate to any ELISA and difficult to control in a diagnostic laboratory environment, is sufficient to cause interpretation problems when an animal's infection status is classified based on a single cutoff point. Because the product in this study, which was originally designed as a herd-level diagnostic tool, is being used more frequently for individual animal management and certification programs, the impact of this error likely will be amplified. Furthermore, with efforts advancing toward a national Johne's disease control program, such errors will potentially impact interstate movement of animals and how well the results of individual diagnostic laboratories are accepted. The conclusion from this study is that reporting results on a continuous numerical scale and incorporating variability into the scheme for classification of results provides substantially more accurate and reliable interpretation of the test. The proposed scheme helps to minimize interpretation problems by identifying those individual test results within a designated prediction interval of the manufacturers cutoff point as suspect, rather than positive or negative. By providing the actual S/P ratios, the testing laboratory provides the owner or herd veterinarian with critical information with which to make sound management or disease-control decisions.
a. HerdChek Mpt, IDEXX, Inc., Portland, ME. b. SAS version 8.1, SAS Institute, Cary, NC.
